Skip to content

13F-HR filed by M28 Capital Management LP

M28 Capital Management LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 11 holding rows worth $101,855,317.

Accession
0000902664-25-000931
Filed
2025-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 11 entries on the cover page, a total value of $101,855,317 stated on the cover page (in dollars after the unit check, H1), rows summing to $101,855,317 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAVE LIFE SCIENCES LTD SHSY95308105Stock5,664,548$70,070,459dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock161,600$4,864,160dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM385,680$4,847,998dollars as filed
INVIVYD INC00534A102COMMON STOCK9,248,250$4,097,900dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM110,400$3,988,752dollars as filed
FRACTYL HEALTH INC35168W103COM1,856,117$3,823,601dollars as filed
BRIDGEBIO PHARMA INC10806X102COM121,200$3,325,728dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO1,019,498$2,701,670dollars as filed
CURIS INC231269309COM521,059$1,594,441dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS185,100$1,273,488dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM67,400$1,267,120dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-25-000931this filing2025-02-13acceptance time not in the bulk data set